External resources FDA information on semaglutide medications for diabetes and obesity SURMOUNT-1 tirzepatide trial in the New England Journal of Medicine For those serious about optimizing their GLP-1 journey, SeekPeptides offers comprehensive protocols, dosing tools, tracking resources, and a community of thousands who have navigated these exact questions
They discovered that being generally obese (having a BMI of 25 or higher) was strongly linked to poor cognition, especially when combined with abdominal obesity (having a larger waist size)
However, because of its unique mechanism of action, further research is needed to see what other side effects are possible.
Picard M, Juster RP, McEwen BS
For those ready to embrace this promising approach, a collaborative, holistic plan involving both medication and lifestyle changes is essential
Cell Tissue Bank